East and South East Asian Ethnicity and Moderate-to-Severe Endometriosis

J Minim Invasive Gynecol. 2019 Mar-Apr;26(3):507-515. doi: 10.1016/j.jmig.2018.06.009. Epub 2018 Jun 20.

Abstract

Study objective: To investigate ethnic differences for moderate-to-severe endometriosis.

Design: Analysis of a prospective registry (Canadian Task Force classification II-2).

Setting: Tertiary referral center.

Patients: A total of 1594 women with pelvic pain and/or endometriosis.

Interventions: None MEASUREMENTS AND MAIN RESULTS: On logistic regression, adjusting for potential confounders, East/South East Asians were 8.3 times more likely than whites to have a previous diagnosis of stage III/IV endometriosis before referral (adjusted odds ratio [aOR], 8.33; 95% confidence interval [CI], 3.74-18.57), 2.7 times more likely to have a palpable nodule (aOR, 2.66; 95% CI, 1.57-4.52), 4.1 times more likely to have an endometrioma on ultrasound (aOR, 4.10; 95% CI, 2.68-6.26), and 10.9 times more likely to have stage III/IV endometriosis at the time of surgery at our center (aOR, 10.87; 95% CI, 4.34-27.21).

Conclusion: Moderate-to-severe endometriosis was more common in women with East or South East Asian ethnicity in our tertiary referral center. This could be explained by East/South East Asians with minimal to mild disease being less likely to seek care or genetic/environmental differences that increase the risk of more severe disease among East/South East Asians. (ClinicalTrials.gov, NCT02911090.).

Keywords: Endometriosis; Ethnicity; Severity; Stage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asia / ethnology
  • Asian People
  • British Columbia / epidemiology
  • Cohort Studies
  • Endometriosis / complications
  • Endometriosis / epidemiology*
  • Endometriosis / ethnology
  • Endometriosis / pathology
  • Ethnicity
  • Female
  • Humans
  • Logistic Models
  • Odds Ratio
  • Pelvic Pain / etiology
  • Prospective Studies
  • Registries
  • Severity of Illness Index

Associated data

  • ClinicalTrials.gov/NCT02911090

Grants and funding